• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新诊断为 2 型糖尿病患者 10 年内血糖控制不佳的时间。

Time in suboptimal glycemic control over 10 years for patients newly diagnosed with type 2 diabetes.

机构信息

Kaiser Permanente Southern California, Pasadena, CA, USA.

Kaiser Permanente Northwest, Portland, OR, USA.

出版信息

J Diabetes Complications. 2020 Aug;34(8):107607. doi: 10.1016/j.jdiacomp.2020.107607. Epub 2020 Apr 27.

DOI:10.1016/j.jdiacomp.2020.107607
PMID:32499115
Abstract

OBJECTIVE

To estimate time in suboptimal glycemic control among patients with incident type 2 diabetes (T2D) over 10 years.

METHODS

We calculated percent of time in suboptimal glycemic control using three A1C thresholds (8%, 7.5%, 7%) following T2D diagnosis. Stratified analyses were conducted based on age and A1C levels at T2D diagnosis.

RESULTS

We identified 28,315 patients with incident T2D. Percent of time in suboptimal glycemic control increased with T2D duration. Mean percent time in suboptimal A1C control in the first 2 years following diagnosis was 30%, 34% and 40% for the 8%, 7.5%, and 7% thresholds, respectively. In the 6-10 years following T2D diagnosis, the percent time in suboptimal A1C control increased to 39%, 48% and 61%, for the 8%, 7.5%, and 7% thresholds, respectively. Time in suboptimal glycemic control was longer among younger patients aged 20-44 versus ≥65 years and those with higher A1C (>8%) versus lower A1C (<7%) at diagnosis.

CONCLUSIONS

Over 10 years following diagnosis, T2D patients spent one-third to over one-half of their time in suboptimal glycemic control. Reducing time spent above desired A1C targets could lower risk of microvascular and macrovascular complications.

摘要

目的

估计新诊断 2 型糖尿病(T2D)患者在 10 年内处于血糖控制不佳状态的时间比例。

方法

我们使用三个糖化血红蛋白(A1C)阈值(8%、7.5%和 7%)计算了 T2D 诊断后血糖控制不佳的时间比例。根据 T2D 诊断时的年龄和 A1C 水平进行了分层分析。

结果

我们确定了 28315 例新诊断的 T2D 患者。血糖控制不佳的时间比例随着 T2D 持续时间的增加而增加。诊断后前 2 年内,血糖控制不佳的平均 A1C 时间比例分别为 8%、7.5%和 7%阈值的 30%、34%和 40%。在 T2D 诊断后 6-10 年内,血糖控制不佳的 A1C 时间比例分别增加至 8%、7.5%和 7%阈值的 39%、48%和 61%。在诊断时年龄较小(20-44 岁)的患者与年龄较大(≥65 岁)的患者和 A1C 较高(>8%)的患者与 A1C 较低(<7%)的患者相比,血糖控制不佳的时间更长。

结论

在诊断后 10 年内,T2D 患者有三分之一至一半以上的时间处于血糖控制不佳的状态。减少高于理想 A1C 目标的时间可能会降低微血管和大血管并发症的风险。

相似文献

1
Time in suboptimal glycemic control over 10 years for patients newly diagnosed with type 2 diabetes.新诊断为 2 型糖尿病患者 10 年内血糖控制不佳的时间。
J Diabetes Complications. 2020 Aug;34(8):107607. doi: 10.1016/j.jdiacomp.2020.107607. Epub 2020 Apr 27.
2
Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: A population-based observational study.香港 2 型糖尿病患者的诊断时年龄、血糖轨迹和口服降血糖药物反应的观察性研究。
PLoS Med. 2020 Sep 18;17(9):e1003316. doi: 10.1371/journal.pmed.1003316. eCollection 2020 Sep.
3
A historical cohort study of glycemic control in patients with concurrent type 2 diabetes and substance use disorder treated in a primary care setting.在初级保健环境中治疗同时患有 2 型糖尿病和物质使用障碍的患者的血糖控制的历史队列研究。
Fam Pract. 2021 Sep 25;38(5):562-568. doi: 10.1093/fampra/cmab008.
4
Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A in the ADVANCE Trial.强化血糖控制对 ADVANCE 试验中不同心血管风险和血红蛋白 A 水平的 2 型糖尿病患者临床结局的影响。
Diabetes Care. 2020 Jun;43(6):1293-1299. doi: 10.2337/dc19-1817. Epub 2020 Mar 19.
5
The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model.在大型综合医疗体系中,血糖控制不佳的 2 型糖尿病患者达到 A1C 目标的概率:预测模型。
Diabetes Care. 2020 Aug;43(8):1910-1919. doi: 10.2337/dc19-0968. Epub 2020 Jun 11.
6
A Multicenter Real-Life Study on the Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 and Type 2 Diabetes.一项关于即时血糖监测对 1 型和 2 型糖尿病患者血糖控制影响的多中心真实世界研究。
Diabetes Technol Ther. 2017 Sep;19(9):533-540.
7
Risk factors for suboptimal glycemic control in pediatrics with type 1 diabetes mellitus: a cross-sectional study.1 型糖尿病患儿血糖控制不佳的危险因素:一项横断面研究。
Sci Rep. 2024 Mar 29;14(1):7492. doi: 10.1038/s41598-024-57205-9.
8
Effectiveness of an Interprofessional Glycemic Optimization Clinic on Preoperative Glycated Hemoglobin Levels for Adult Patients With Type 2 Diabetes Undergoing Bariatric Surgery.多专业协作的血糖优化门诊对接受减重手术的 2 型糖尿病成年患者术前糖化血红蛋白水平的影响。
Can J Diabetes. 2018 Oct;42(5):514-519. doi: 10.1016/j.jcjd.2017.12.011. Epub 2017 Dec 26.
9
Hemoglobin A1c Threshold for Reduction in Bone Turnover in Men With Type 2 Diabetes Mellitus.血红蛋白 A1c 降低对 2 型糖尿病男性骨转换的影响。
Front Endocrinol (Lausanne). 2021 Dec 28;12:788107. doi: 10.3389/fendo.2021.788107. eCollection 2021.
10
Disordered glycemic control in women with type 2 diabetes is associated with increased TNF receptor-2 levels.2型糖尿病女性患者血糖控制紊乱与肿瘤坏死因子受体2水平升高有关。
J Diabetes Complications. 2021 Sep;35(9):107974. doi: 10.1016/j.jdiacomp.2021.107974. Epub 2021 Jun 19.

引用本文的文献

1
Costs and Health Care Utilization Analysis of Medical Group Visits for Adults With Type 2 Diabetes in Community Health Centers.社区卫生中心中 2 型糖尿病成年患者的医疗小组访视的成本和医疗利用分析。
Med Care. 2023 Dec 1;61(12):866-871. doi: 10.1097/MLR.0000000000001937. Epub 2023 Oct 11.
2
Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01).真实世界中皮下司美格鲁肽治疗 2 型糖尿病的疗效:一项回顾性队列研究(Sema-MiDiab01)。
Front Endocrinol (Lausanne). 2023 Jan 18;13:1099451. doi: 10.3389/fendo.2022.1099451. eCollection 2022.
3
The impairment of the deep vascular complex in prolonged type 2 diabetes patients without clinical diabetic retinopathy.
无临床糖尿病视网膜病变的长期2型糖尿病患者深部血管复合体的损伤
PLoS One. 2022 Jun 3;17(6):e0269182. doi: 10.1371/journal.pone.0269182. eCollection 2022.
4
Key Considerations for Understanding Usability of Digital Health Initiatives for Adults With Type 2 Diabetes: A Systematic Qualitative Literature Review.理解数字健康干预措施在 2 型糖尿病成年患者中的可用性的关键考虑因素:系统定性文献综述。
J Diabetes Sci Technol. 2023 May;17(3):833-842. doi: 10.1177/19322968221075322. Epub 2022 Feb 7.
5
Efficacy of Semaglutide in a Subcutaneous and an Oral Formulation.司美格鲁肽皮下制剂和口服制剂的疗效。
Front Endocrinol (Lausanne). 2021 Jun 25;12:645617. doi: 10.3389/fendo.2021.645617. eCollection 2021.